MNL Group

MNL Group, also known as Maqui New Life, is a Chilean nutraceutical and biotechnology company focused on the research, development, and commercialization of standardized maqui berry extracts for human and animal health. Founded in 2010 as a spin-off from CTI Salud, the company has built a portfolio of clinically studied ingredients including Delphinol, MaquiBright, and Futerpenol. Its products are positioned for nutraceutical, functional food, dietary supplement, and animal nutrition applications, with claimed benefits spanning glucose metabolism, eye hydration, skin health, antioxidant support, and immune resilience. The company emphasizes scientific validation, traceability, and sustainable wild harvesting in Patagonia, and appears to operate globally through distribution and commercial partners. Based on available information, MNL Group is not a traditional drug-development biotech with a clinical therapeutic pipeline, but rather a commercial-stage health-ingredient company.